Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospitals Cleveland Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 or older at time of enrollment
Documented diagnosis of Obsessive Compulsive Disorder (OCD)
Y-BOCS score of 28 or higher confirmed with behavioral testing during pre-existing clinical documentation
Two trials of selective serotonin reuptake inhibitors for an adequate duration at maximally tolerated dose OR one trial of a selective serotonin reuptake inhibitor with antipsychotic augmentation for an adequate duration at maximally tolerated dose OR one trial of a selective serotonin reuptake inhibitor and clomipramine for an adequate duration at maximally tolerated dose
Nonresponse to at least one trial of Exposure-Response Prevention behavioral therapy for an adequate duration.
Patient able to understand written and spoken English
You may not be if
Patient has prior ablative procedure to the brain (radiofrequency ablation, thermal ablation, laser interstitial thermal therapy, high-frequency ultrasound)
Patient has MRI contraindications (cardiac implantable electronic devices, metallic intraocular foreign bodies, implantable neurostimulation systems, cochlear or ear implants, and drug infusion pumps)
Pregnant women are excluded from this study.
Patient has prior diagnosis of brain tumor
Patient has active suicidal thoughts as assessed by a mental health professional
Patient has comorbid neurodegenerative disorder
Patient has history of substance use disorder in the past 24 months
Patient deemed by study investigator to lack capacity to provide informed consent.